Lungs News and Research

RSS

FDA Advisory Committee votes against the approval of Tarceva

OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.

17 Dec 2009

KarmelSonix selects Blackfin digital signal processors from Analog Devices

Analog Devices, Inc. announced today that KarmelSonix, pioneers in medical device development for asthma management, have chosen Analog Devices’ Blackfin digital signal processors and advanced signal chain components to power its products.

17 Dec 2009

Researchers discover new gene involved in lung cancer using DNA sequencing technology

Aided by next-generation DNA sequencing technology, an international team of researchers has gained insights into how more than 60 carcinogens associated with cigarette smoke bind to and chemically modify human DNA, ultimately leading to cancer-causing genetic mutations.

17 Dec 2009

$15 million federal funds for new cancer research program

As a result of C3: Colorectal Cancer Coalition's advocacy efforts, $15 million for a new peer reviewed cancer research program is included in the final Fiscal Year 2010 Defense Appropriations Bill.

17 Dec 2009

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

Boston University School of Medicine's (BUSM) Pulmonary Center has received a two-year $1.4 million grant from the National Heart, Lung, and Blood Institute to derive stem cells and lung progenitors from patients with lung disease.

16 Dec 2009

Patients involved in Novelos Therapeutics' pivotal Phase III trial live longer than expected

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.

16 Dec 2009

Drug monitoring may provide alternative treatments for patients with severe H1N1

An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.

16 Dec 2009

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

A new study links chronic obstructive pulmonary disease, or COPD, with increased activity of cells that act as sentinels to activate the body's immune system.

15 Dec 2009

Seven tips to quit smoking

Many people will make New Year's resolutions to quit smoking this year. With a still uncertain economy, quitting smoking is good both for your health and your wallet. Having a solid smoking cessation plan can greatly improve a person's chance for success.

15 Dec 2009

Antidepressant and anti-anxiety medications linked to increased risk of cardiovascular events and death

Women with suspected coronary artery disease (CAD) who report taking antidepressant and anti-anxiety medications have an increased risk of cardiovascular events, including heart attacks and strokes, and death compared to women not taking these medications, according to researchers at the Uniformed Services University of the Health Sciences (USU).

15 Dec 2009

Ethanol can worsen global health problems

Ethanol, often promoted as a clean-burning, renewable fuel that could help wean the nation from oil, would likely worsen health problems caused by ozone, compared with gasoline, especially in winter, according to a new study led by Stanford researchers.

15 Dec 2009

Findings raise new hope for asthma and chronic obstructive pulmonary disease

A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity.

15 Dec 2009

Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint Conference

In partnership with the International Association for the Study of Lung Cancer, the American Association for Cancer Research will host the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, which will bring together leaders from all over the world who share the goal of eradicating this form of cancer.

15 Dec 2009

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Researchers at the Los Angeles Biomedical Research Institute (LA BioMed) expect to receive more than $4.5 million in grants from the American Recovery and Reinvestment Act (Recovery Act.), including nearly $1 million from the highly competitive Challenge Grant program for a study that seeks to reduce the number of children who die from Sudden Infant Death Syndrome, it was announced today.

15 Dec 2009

Premature newborn boys have poorer prognosis compared to newborn girls, says study

Among premature births - children born before the 37th week of pregnancy - newborn boys have a poorer prognosis than newborn girls. In her dissertation at Lund University in Sweden, the physician Emma Elsmén Steen has explored why male gender constitutes a risk factor for greater morbidity in these infants.

14 Dec 2009

Clarient and BioView team up to develop diagnostic tool for early detection of lung cancer

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd. (TASE: BIOV) today jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.

14 Dec 2009

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

14 Dec 2009

Several DNA sequences linked to impaired pulmonary function, uncovers new study

14 Dec 2009

Scientists discover five genetic variants associated with lung disease

Scientists have discovered five genetic variants that are associated with the health of the human lung. The research by an international consortium of 96 scientists from 63 centres in Europe and Australia sheds new light on the molecular basis of lung diseases.

14 Dec 2009

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine.

13 Dec 2009

Lungs News and Research

FDA Advisory Committee votes against the approval of Tarceva

KarmelSonix selects Blackfin digital signal processors from Analog Devices

Researchers discover new gene involved in lung cancer using DNA sequencing technology

$15 million federal funds for new cancer research program

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

Patients involved in Novelos Therapeutics' pivotal Phase III trial live longer than expected

Drug monitoring may provide alternative treatments for patients with severe H1N1

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

Seven tips to quit smoking

Antidepressant and anti-anxiety medications linked to increased risk of cardiovascular events and death

Ethanol can worsen global health problems

Findings raise new hope for asthma and chronic obstructive pulmonary disease

Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint Conference

Researchers to receive more than $4.5 million in grants to study Sudden Infant Death Syndrome

Premature newborn boys have poorer prognosis compared to newborn girls, says study

Clarient and BioView team up to develop diagnostic tool for early detection of lung cancer

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

Several DNA sequences linked to impaired pulmonary function, uncovers new study

Scientists discover five genetic variants associated with lung disease

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News